D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results
Ziming Li, Zhengbo Song, Yanqiu Zhao, Pingli Wang, Liyan Jiang, Yi Gong, Jianying Zhou, Hong Jian, Xiaorong Dong, Zhuang Wu, Shundong Cang, Nong Yang, Jian Fang, Jianhua Shi, Jun‐Guo Lu, Rui Ma, Ping Wu, Yingqian Zhang, Mengmeng Song, Chunwei Xu, Zhe Shi, Ling Zhang, Yaolin Wang, Xicheng Wang, Yiping Zhang, Shun Lü
Topics & Concepts
MedicinePharmacologyOncologyInternal medicineProtein Kinase Regulation and GTPase SignalingMelanoma and MAPK PathwaysColorectal Cancer Treatments and Studies